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Aortic valve stenasis may present throughout life, from she
neonate to the very elderly . In the very young with aortic
valve stenosis, the valve is frequently unicuspid orbicuspid
and is tricuspid in 15%; in the age group 15 to 65 yam, the
valve is most frequently bicuspid (60%) and is tricuspid in
25% (1) . In patients >65 years ofege, the valve is tricuspid
in90% (1) . At the two ends of the spectrum of life, the results
of catheter balloon valvuloplasty for severe aortic valve
stenosis are didferent.
Catheter balloon velvuleplasty for severe aortic valve
genesis in children mini adolescents was initially reported by
Iebabidi et al, (2). In such padats, as well as in "young"
adults with monosis that is largely a result of cmnmisaural
adhesions, rite results of catheter balloon valvuloplesty are
generally good to excellent because this procedure produces
an increase in aortic va . a are by commissural splitting and
stretching of valve tissue (3). As a result, catheter balloon
valvuloplamy is the procedure or Oral choice in selected
patients in the pediatric age group and in young adults with
severe aortic valve genesis (4).
Caldlk awde don" I elder patsntst badigcod .
Catheter balloon valvuloplasty fur cakbfle nurttc valve ste-
nosin was Wally reported by Cts'bie ct ul . (5) in older or
elderly patients. R. 0. McKay et al. (6) showed that in these
patients. increase in sole valve area occurred largely by
fracture of the calcted lealet and by displacement and
stretching of rigid valve cusps ; eommissural separation may
also occur. From the earliest reports, it was noted alter
"succesafal" catheter balloon valvuloplasly that aortic
valve area was small, and aortic valve stenosis was still den
severity that was 1) known to be associated with a very poor
prognosis, and 2) usually considered an ingdemin for act*
valve replacement (7). It was also pointed outd that lime
that unless aortic valve area after catheter balloon valvule-
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plasty increased by a much greater amount without produc-
ing increased aortic regurgitation . catheter balloon valvulo-
plasty will not match the favorable reaulls of aortic valve
replacement m hemodynalnics and symptomatic status, left
ventricular funnlon and survival (7) .
Results eicthder balloon velvdspmoly. Further studies
have shown that catheter balloon valvuloplasty for calcific
aortic valve atenoais Faults in a similar average increase in
aortic valve area. that is. only 0 .3 to 0d mar , and t70% of
patients have ao sonic valve area after catheter balloon
valvpleplasty eLO cm' (8,9). Patents with a larger aortic
valve area titer catheter balloon valvdnplasty usually have
a larger aortic valve area before catheter balloon valvulo-
phely. Restenosis occurs commonly and rapidly, that is, in
42% In 83% of patients at an average f)llow-up of 5 to 9
months, rite teateooeis rate is higher when the aortic valve
area after catheter balloon vnivuloplasty is <0 .7 cm2 and
when the Increase in sonic valve area after Catheter balloon
valvuloplasty is small (8,9). Complications occur in many
patients depending on the experience of the mterventiu mlist
and the clinical status of the patient . Data from the National
Heart, Lung, and Blood lnstilute (NHLBI) Registry (10)
showed that 30 days niter atheae balloon valvuloplasty,
66% of patients had improved their New York Ham Asso-
ciation functional close, 28% were unchanged. and 6% bad a
worsening of their symptomatic state. Fifteen percent of
patients who were in functional clam I before catheter
balloon valvulopiasty were in flectimmel claw BI after
catheter balloon valvuloplasty, presumably because they
developed severe amts valve regeegitatus
. This experience
mdintaa dot cam" should be exercised in rocosomendinS
this procedure in asymptoenatic patients, and averaiolng or
balloons should he avoided- Impaired left ventricular ejec .
lion fraction before catheter balloon valvuloplamy my not
change in about one-half or more of patients but shows a
name increase in the othM (9) .
On blow-up, rtrtma . . y has been high . At 6 months. the
mortality rare low been reported to be 15% to 22% (8). At 1
Year
. the reported acmmrial mortality rates were 24%, 43%
and 60%; -25% of patients had underpass: repeal catheter
balloon valvuloplnsty or anetle valve replacement (e), in a
series of 170 pdiats, the mortality rate at 12 months was
28%, and SO% of patients had an event (death or symptoms)
(11). The Mamheld Scientific: Registry of 492 patients
showed that the I-year mortality rate was 36% (12). The
I-Y= mortality ale in those patients with AV areas s0
.7
MW
>0,7 cm= alter catheter balloon valvuloplasty was 37%
ad 42%, respectively (p - 0.105) (l2) .
Recently, the NHLBI Registry
reported
the 3-year out-
come of 674 patients
(13). The mm
age was 78 ± 9 years .
and left ventricular ejection fraction was normal or mildly
reduced in 64%
. Acetic
valve area had increased from 0
.5
:t
0.2 tea.& ± 0.3 car. The I.. 2-and 3-yearmortality rate was
45%. 65% and 77%, respectively ; 70% of the deaths were
cardiac in cause. The 3-year mortality rate in those patients
oror-awhoaSEm
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Table 1
. Suggested Indications for Catheter Balloon Valwkoplasty
in Patients With Calcite Seven, Aortic Valve Stenosis°t
1.
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with normal and severely reduced left ventricular systole
function was 69% and 91%, respectively .
Reasons far poor survival alter catheter balloon valvulp-
phsty. There are at least three mu or reasons fee poor
survival after catheter balloon valvuloplasty for severe eal-
dOe aortic valve stcnosis:1) Most patients (?70%) still have
severe aortic valve stemnis (aortic valve area s1
.0 core)
after catheter balloon valvuloplasty . Therefore, it shook( not
be a surprise if their outcome is similar to that of the animal
history of severe cold& aortic valve stetavsis (8) . 2) The
incidence of sigad' scantly obstructive coronary artery disease
in such patients is -50% (14 .15). In the NHLBI Registry,
percutaneous tranalumhml coronary angioplasty and coro-
nary artery bypass surgery were performed in 1% and 591 of
patients, respectively (13)
.
that is. most likely in a small
minority of patients who bad associated coronary artery
disease . La the presence of obstructive coronary artery
dismse, nonrevasculadzed myocardium, particularly in pa-
tients with left ventricular hypertrophy and severe aortic
valve ateaosis, can be expected to he associated with an
increased mortality. 3) Many patients have associated co-
morbid factors (16)
.
ksYndonsAw~Wheter6actoeDvalauloplasly. The current
suggested recommendations for catheter balloon valvulo-
plenty are summarized in Table 1 . These am derived from a
consideration oftlr results of cateter balloon valvuksplasty
summarized above and the known results of aortic valve
replacement . which improve hemodynnmic status, func-
tional ebsa. left ventricular function and survival, aid have
been summarized elsewhere (8,17) .
Cardlogaiedesek . Five previous reports of 1,2, 3, ]and
10 patients, respectively. who were in cardiogenic shock
wslh severe aortic valve stettosis and underwent catheter
balsam valvuloplasty showed either good or poor results
nitially bit, subsequently. the patients fared poorly (18-22)
.
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In the NHLBI registry data of eatheterballoan valvuloplasty
for aortic valve stenosis, 39 (6%) of 674 patients had cardio-
genic shock (13). In the current issue of the Journal, Memo
or al- (231 also report that 21 (6%) of 310 patients at the
Massachusetts General Hospital had cardiogenic shoer . It is
likely that some patients in the Moreno el al
. study (23) were
also included in the NHLBI Registry (13).
The in-Imspital mortality rate (21 t 2 days) in the Moreno
cn al . study was 43%. and the 30-day mortality in the NHLBI
Registry was 49%,
The Moreno co d- study is important and
provides longer fellow-op
; of 12 surviving patients, 5 died
subsequently of cordite cause, almost all in the early fol-
low-up period (23)
. Three patients underwent elective aortic
valve replacement, and two were in hmctional classes 1 and
11 at 21 ± 3 months after conic valve replacement
. Eight
patients did not undergo operation
. Five of these patients
had
major
comorind conditions Boiling the patient's life
span. and three refused operation ; three patients died, all of
cardiac cause .
One reason for the very high mortality is the associated
major comarbid conditions that were present in all 21
patients in the Moreno d al. (23) study and was the cause of
or a contributing factor to the demise of the patients
.
However. many patients still died of a cardiac cause
. More-
over . some patents were young (menn age 74 ± 3 years,
range 35 to
901 and some had normal left ventricular ejection
friction (men value 29 ± 3%, range 15% to 61%). In some
patients, serum creatnine war as low as 1 .7 mg%. It is
possible that in some patients renal failure was secondary to
reduced cardiac output and hypoleasion. Only 8 (38%) of 21
patients had associated coronary artery disease, and 5 (63%)
of these a had not had previous coronary artery bypass
surgery and could thus, presumably, undergo revasculariza-
tion . It is of interest that 11 (52%) of [he 21 patients had
evidence of non-Q wave myocardial infection at time of
presentation. and I of the 2 patients who died during the
procedure had naa-Q wave myocardial infarction before
catheter balloon valvuloplasty and al autopsy had extensive
c rcumferential sabeadocardial necrosis with normal coro-
nary arteries (23) . The duration of shock or hypmension, or
both, is not mentioned ; it is likely that most patients initially
were heated at another hospital . B must be recognized that
the hypertrophied heart (24), particularly out due to aortic
stenosis, is ar major risk for subendocardlal myocardial
ischemin, even in the absence of associated coronary artery
disease . Hypotension or associated coronary artery disease,
or both, could initiate a vicious cycle of myocardial inch-
emit, leading to or exacerbating left ventricular dysfunction,
which could further reduce myocardial perfusion and in-
crease myocardial ischtsrda, and sobendocardial myocardial
infarction could be precipitated .
There am at least four important guidelines that have to
be kept in mind in managing such patients : 1) Patients with
severe aortic valve ate sesis who are in heart failure and are
hyp sensive (cardiogenic shock) constitute a medical emer-
gency
. Pharmacologic therapy and bedside hentodynamic
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